The ubiquitin proteasome system plays a role in Venezuelan equine encephalitis virus infection

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Amaya, Moushimi ^a   Keck, Forrest ^a   Lindquist, Michael ^b   Voss, Kelsey ^a   Scavone, Lauren ^a   Kehn Hall, Kylene ^a   Roberts, Brian ^c   Bailey, Charles ^a   Schmaljohn, Connie ^b   Narayanan, Aarthi ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; PROTEASOME; UBIQUITIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; ASTROCYTOMA CELL; CATALYSIS; CELL SURVIVAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; EASTERN EQUINE ENCEPHALITIS VIRUS; EMBRYO; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; UBIQUITINATION; VENEZUELAN EQUINE ENCEPHALITIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; WESTERN EQUINE ENCEPHALITIS VIRUS; ANIMAL; DRUG EFFECTS; GUINEA PIG; METABOLISM; PATHOGENICITY; VENEZUELAN EQUINE ENCEPHALITIS VIRUS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BORTEZOMIB; CELL SURVIVAL; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; GUINEA PIGS; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION, FLUORESCENCE; PROTEASOME ENDOPEPTIDASE COMPLEX; TANDEM MASS SPECTROMETRY; UBIQUITIN;

EID: 84944087308     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124792     Document Type: Article

References (43)

1. Jackson G, Einsele H, Moreau P, Miguel JS. Bortezomib, a novel proteasome inhibitor, in the treatment of hematologic malignancies. Cancer Treat Rev. 2005;31:591-602. PMID: 16298074
2. Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, Crews CM. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci USA. 1999;96:10403-10408. PMID: 10468620
3. Satheshkumar PS, Anton LC, Sanz P, Moss B. Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes. J Virol. 2009;83:2469-2479. doi: 10.1128/JVI.01986-08 PMID: 19129442
4. Curran MP, McKeage K. Bortezomib: a review of its use in patients with multiple myeloma. Drugs. 2009;69:859-888. doi: 10.2165/00003495-200969070-00006 PMID: 19441872
5. Mateos MV. Role of bortezomib for the treatment of previously untreated multiple myeloma. Expert Rev Hematol. 2008;1:17-28. doi: 10.1586/17474086.1.1.17 PMID: 21083004
6. Schneider M, Ackermann K, Stuart M, Wex C, Protzer U, Schätzl HM, et al. Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain. J Virol. 2012;86:10112-10122. doi: 10.1128/JVI.01001-12 PMID: 22787216
7. Khor R, McElroy LJ, Whittaker GR. The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic. 2008;4:857-868.
8. Widjaja I, de Vries E, Tscherne DM, García-Sastre A, Rottier PJ, de Haan CA. Inhibition of the ubiquitinproteasome system affects influenza A virus infection at a postfusion step. J Virol. 2010;84:9625-9631. doi: 10.1128/JVI.01048-10 PMID: 20631148
9. Delboy MG, Roller DG, Nicola AV. Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step. J Virol. 2008;82:3381-3390. doi: 10.1128/JVI.02296-07 PMID: 18234803
10. Si X, McManus BM, Zhang J, Yuan J, Cheung C, Esfandiarei M, et al. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway. J Virol. 2005;79:8014-8023. PMID: 15956547
11. Raaben M, Posthuma CC, Verheije MH, te Lintelo EG, Kikkert M, Drijfhout JW, et al. The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle. J Virol. 2010;84:7869-7879. doi: 10.1128/JVI.00485-10 PMID: 20484504
12. Horan KA, Hansen K, Jakobsen MR, Holm CK, Søby S, Unterholzner L, et al. Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors. J Immunol. 2013;190:2311-2319. doi: 10.4049/jimmunol.1202749 PMID: 23345332
13. Schubert U, Ott DE, Chertova EN, Welker R, Tessmer U, Princiotta MF, et al. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci USA. 2000;97:13057-13062. PMID: 11087859
14. Aguilar PV, Greene IP, Coffey LL, Medina G, Moncayo AC, Anishchenko M, et al. Endemic Venezuelan equine encephalitis in northern Peru. Emerg Infect Dis. 2004;10:880-888. PMID: 15200823
15. Foy NJ, Akhrymuk M, Akhrymuk I, Atasheva S, Bopda-Waffo A, Frolov I, et al. Hypervariable domains of nsP3 proteins of New World and Old World alphaviruses mediate formation of distinct, virus-specific protein complexes. J Virol. 2013;87:1997-2010. doi: 10.1128/JVI.02853-12 PMID: 23221551
16. Kim DY, Atasheva S, Frolova EI, Frolov I. Venezuelan equine encephalitis virus nsP2 protein regulates packaging of viral genome into infectious virions. J Virol. 2013;87:4202-4213. doi: 10.1128/JVI. 03142-12 PMID: 23365438
17. Lamb K, Lokesh GL, Sherman M, Watowich S. Structure of a Venezuelan equine encephalitis virus assembly intermediate isolated from infected cells. Virology. 2010;406:261-269. doi: 10.1016/j.virol. 2010.07.009 PMID: 20701942
18. Steele KE, Twenhafel NA. REVIEW PAPER: pathology of animal models of alphavirus encephalitis. Vet Pathol. 2010;47:790-805. doi: 10.1177/0300985810372508 PMID: 20551475
19. Bhomia M, Sharma A, Gayen M, Gupta P, Maheshwari RK. Artificial microRNAs can effectively inhibit replication of Venezuelan equine encephalitis virus. Antiviral Res. 2013;100:429-434. doi: 10.1016/j. antiviral.2013.08.010 PMID: 23988697
20. Tretyakova I, Lukashevich IS, Glass P, Wang E, Weaver S, Pushko P. Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine. Vaccine. 2013;31:1019-1025. doi: 10.1016/j.vaccine.2012.12.050 PMID: 23287629
21. Zacks MA, Paessler S. Encephalitic alphaviruses. Vet Microbiol. 2010;140:281-286. doi: 10.1016/j. vetmic.2009.08.023 PMID: 19775836
22. Spurgers KB, Hurt CR, Cohen JW, Eccelston LT, Lind CM, Lingappa VR, et al. Validation of a cellbased ELISA as a screening tool identifying anti-alphavirus small-molecule inhibitors. J Virol Methods. 2013;193:226-231. doi: 10.1016/j.jviromet.2013.06.007 PMID: 23764417
23. Barber TL, Walton TE, Lewis KJ. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses. Am J Vet Res. 1978;39:621-625. PMID: 646197
24. Garmashova N, Gorchakov R, Volkova E, Paessler S, Frolova E, Frolov I. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J Virol. 2007;81:2472-2484. PMID: 17108023
25. Weaver SC, Ferro C, Barrera R, Boshell J, Navarro JC. Venezuelan equine encephalitis. Annu Rev Entomol. 2004;49:141-174. PMID: 14651460
26. Jose J, Snyder JE, Kuhn RJ. A structural and functional perspective of alphavirus replication and assembly. Future Microbiol. 2009;4:837-856. doi: 10.2217/fmb.09.59 PMID: 19722838
27. Weaver SC, Barrett AD. Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol. 2004;2:789-801. PMID: 15378043
28. Amaya M, Voss K, Sampey G, Senina S, de la Fuente C, Mueller C, et al. The role of IKKβ in Venezuelan equine encephalitis virus infection. PLoS One. 2014;9:e86745. doi: 10.1371/journal.pone. 0086745 PMID: 24586253
29. Atasheva S, Fish A, Fornerod M, Frolova EI. Venezuelan equine Encephalitis virus capsid protein forms a tetrameric complex with CRM1 and importin alpha/beta that obstructs nuclear pore complex function. J Virol. 2010;84:4158-4171. doi: 10.1128/JVI.02554-09 PMID: 20147401
30. Atasheva S, Krendelchtchikova V, Liopo A, Frolova E, Frolov I. Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein. J Virol. 2010;84:10004-10015. doi: 10.1128/JVI.01151-10 PMID: 20668087
31. Garmashova N, Atasheva S, Kang W, Weaver SC, Frolova E, Frolov I. Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription. J Virol. 2007;81:13552-13565. PMID: 17913819
32. Kinney RM, Johnson BJ, Welch JB, Tsuchiya KR, Trent DW. The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology. 1989;170:19-30. PMID: 2524126
33. Narayanan A, Kehn-Hall K, Senina S, Lundberg L, Van Duyne R, Guendel I, et al. Curcumin inhibits Rift Valley fever virus replication in human cells. J Biol Chem. 2012;287:33198-33214. PMID: 22847000
34. Kehn-Hall K, Narayanan A, Lundberg L, Sampey G, Pinkham C, Guendel I, et al. Modulation of GSK-3beta activity in Venezuelan equine encephalitis virus infection. PLoS One. 2012;7:e34761. doi: 10. 1371/journal.pone.0034761 PMID: 22496857
35. Julander JG, Skirpstunas R, Siddharthan V, Shafer K, Hoopes JD, Smee DF, et al. C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Antiviral Res. 2008;78:230-241. doi: 10.1016/j.antiviral.2008.01.007 PMID: 18313150
36. Guo N, Peng Z. MG132, a proteasome inhibitor, induces apoptosis in tumor cells. Asia Pac J Clin Oncol. 2013;9:6-11. doi: 10.1111/j.1743-7563.2012.01535.x PMID: 22897979
37. Taylor RT, Best SM. Assessing ubiquitination of viral proteins: Lessons from flavivirus NS5. Methods. 2011;55:166-171. doi: 10.1016/j.ymeth.2011.08.003 PMID: 21855635
38. Pisano MB, Oria G, Beskow G, Aguilar J, Konigheim B, Cacace ML, et al. Venezuelan equine encephalitis viruses (VEEV) in Argentina: serological evidence of human infection. PLoS Negl Trop Dis. 2013;7:e2551. doi: 10.1371/journal.pntd.0002551 PMID: 24349588
39. Randow F, Lehner PJ. Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol. 2009;11:527-534. doi: 10.1038/ncb0509-527 PMID: 19404332
40. Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates. Chem Biol. 2001;8:739-758. PMID: 11514224
41. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 1998;8:397-403. PMID: 9789328
42. Ma XZ, Bartczak A, Zhang J, Khattar R, Chen L, Liu MF, et al. Proteasome inhibition in vivo promotes survival in a lethal murine model of severe acute respiratory syndrome. J Virol. 2010;84:12419-12428. doi: 10.1128/JVI.01219-10 PMID: 20861244
43. Wang YE, Park A, Lake M, Pentecost M, Torres B, Yun TE, et al. Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. PLoS Pathog. 2010;6:e1001186. doi: 10.1371/journal.ppat.1001186 PMID: 21085610